Design and synthesis of aryloxypropanolamine as β3-adrenergic receptor antagonist in cancer and lipolysis

被引：11
|
作者：
Jin, Jiyu [1 ]
Miao, Chunxiao [2 ]
Wang, Zhilong [3 ]
Zhang, Wanli [2 ]
Zhang, Xiongwen [2 ]
Xie, Xin [3 ,4 ]
Lu, Wei [1 ]
机构：
[1] East China Normal Univ, Sch Chem & Mol Engn, 3663 North Zhongshan Rd, Shanghai, Peoples R China
[2] East ChinaNormal Univ, Sch Chem & Mol Engn, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Shanghai, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, CAS Key Lab Receptor Res, Shanghai, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 150卷
关键词：
beta-Adrenergic receptor; Antagonist; Cancer; Lipolysis and cachexia; MICE; METASTASIS; CACHEXIA; SWITCH;
D O I：
10.1016/j.ejmech.2018.03.032
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
beta-adrenergic receptors (beta-ARs) are broadly distributed in various tissues and regulate a panel of important physiological functions and disease states including cancer. Above all, beta(3)-adrenergic receptor (beta(3)-AR) plays a significant role in regulating lipolysis and thermogenesis in adipose tissue. In this study, we designed and synthesized a series of novel L-748,337 derivatives as selective human beta(3)-AR antagonists. Among all the tested L-748,337 analogs, compound 23d was found to display 23-fold more potent beta(3)-AR antagonist activity (EC50 = 0.5117 nM) than L-748,337 (EC50 = 11.91 nM). In vivo, compound 23d could alleviate weight loss and inhibit tumor growth in C26 tumor cachexia animal model. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：757 / 770
页数：14
相关论文
共 50 条
  • [41] EP3 receptor antagonist L798, 106 reduces proliferation and migration of SK-BR-3 breast cancer cells
    Hester, Anna
    Salzmann, Barbara
    Rahmeh, Martina
    Kolben, Thomas
    Czogalla, Bastian
    Ditsch, Nina
    Mahner, Sven
    Jeschke, Udo
    Kolben, Theresa Maria
    ONCOTARGETS AND THERAPY, 2019, 12 : 6053 - 6068
  • [42] α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway
    Wang, Weina
    Guo, Xin
    Dan, Huiwen
    ONCOTARGETS AND THERAPY, 2020, 13 : 10535 - 10546
  • [43] Design and synthesis of histamine H3/H4 receptor ligands with a cyclopropane scaffold
    Watanabe, Mizuki
    Kobayashi, Takaaki
    Ito, Yoshihiko
    Fukuda, Hayato
    Yamada, Shizuo
    Arisawa, Mitsuhiro
    Shuto, Satoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (23-24) : 3630 - 3633
  • [44] Design and synthesis of novel orexin 2 receptor agonists with a 1,3,5-trioxazatriquinane skeleton
    Amezawa, Mao
    Yamamoto, Naoshi
    Nagumo, Yasuyuki
    Kutsumura, Noriki
    Ishikawa, Yukiko
    Yanagisawa, Masashi
    Nagase, Hiroshi
    Saitoh, Tsuyoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 82
  • [45] The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation
    Farhoumand, Lina S.
    Fiorentzis, Miltiadis
    Kraemer, Miriam M.
    Sak, Ali
    Stuschke, Martin
    Rassaf, Tienush
    Hendgen-Cotta, Ulrike
    Bechrakis, Nikolaos E.
    Berchner-Pfannschmidt, Utta
    CANCERS, 2022, 14 (13)
  • [46] Synthesis, Anti-hypertensive Effect of a Novel Angiotensin II AT1 Receptor Antagonist and its Anti-tumor Activity in Prostate Cancer
    Da, Y. -J.
    Yuan, W. -D.
    Zhu, L. -F.
    Chen, Z. -L.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (12): : 637 - 643
  • [47] Design and Synthesis of New 1,3,5-Trisubstituted Triazines for the Treatment of Cancer and Inflammation
    Zacharie, Boulos
    Abbott, Shaun D.
    Duceppe, Jean-Simon
    Gagnon, Lyne
    Grouix, Brigitte
    Geerts, Lilianne
    Gervais, Liette
    Sarra-Bournet, Francois
    Perron, Valerie
    Wilb, Nicole
    Penney, Christopher L.
    Laurin, Pierre
    CHEMISTRYOPEN, 2018, 7 (09): : 737 - 749
  • [48] Design, synthesis, and biological evaluation of 5'-deoxy (N)-methanocarbanucleoside derivatives as A3 adenosine receptor ligands
    Kim, Minjae
    Naik, Siddhi D.
    Kim, Seung Woo
    Joung, Misuk
    Yum, Yun A.
    Aswar, Vikas R.
    Jeong, Lak Shin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 120
  • [49] Analogues of 3-Hydroxyisoxazole-Containing Glutamate Receptor Ligands Based on the 3-Hydroxypyrazole-Moiety: Design, Synthesis and Pharmacological Characterization
    Jorgensen, Lars
    Nielsen, Birgitte
    Pickering, Darryl S.
    Kristensen, Anders S.
    Frydenvang, Karla
    Madsen, Ulf
    Clausen, Rasmus P.
    NEUROCHEMICAL RESEARCH, 2014, 39 (10) : 1895 - 1905
  • [50] Convergent Synthesis of the Potent P2Y Receptor Antagonist MG 50-3-1 Based on a Regioselective Ullmann Coupling Reaction
    Baqi, Younis
    Mueller, Christa E.
    MOLECULES, 2012, 17 (03) : 2599 - 2615
12345